We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-11.4%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$57.4B
AUM Growth
-$7.29B
Cap. Flow
+$861M
Cap. Flow %
1.5%
Top 10 Hldgs %
21.3%
Holding
3,843
New
205
Increased
1,398
Reduced
1,819
Closed
309

Sector Composition

Rank Sector Weight
1 Technology 9.78%
2 Financials 8.85%
3 Healthcare 8.68%
4 Industrials 6.29%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALLO icon
2326
Allogene Therapeutics
ALLO
$683M
$673K ﹤0.01%
+25,000
New +$664K
CHI
2327
Calamos Convertible Opportunities and Income Fund
CHI
$1.08B
$673K ﹤0.01%
75,929
-17,491
-19% -$174K
YELP icon
2328
Yelp
YELP
$1.32B
$673K ﹤0.01%
19,226
-78,485
-80% -$3M
ANIP icon
2329
ANI Pharmaceuticals
ANIP
$1.72B
$671K ﹤0.01%
14,903
+2,998
+25% +$157K
OMER icon
2330
Omeros
OMER
$1.26B
$671K ﹤0.01%
60,200
+12,900
+27% +$181K
ESGD icon
2331
iShares ESG Aware MSCI EAFE ETF
ESGD
$12.3B
$670K ﹤0.01%
+11,675
New +$709K
PEO
2332
Adams Natural Resources Fund
PEO
$772M
$670K ﹤0.01%
47,826
-22,406
-32% -$372K
SSL icon
2333
Sasol
SSL
$7.17B
$669K ﹤0.01%
22,841
-1,575
-6% -$51.1K
AWF
2334
AllianceBernstein Global High Income Fund
AWF
$878M
$668K ﹤0.01%
63,415
-16,574
-21% -$183K
RMT
2335
Royce Micro-Cap Trust
RMT
$780M
$668K ﹤0.01%
90,015
+11,133
+14% +$95.6K
GMF icon
2336
State Street SPDR S&P Emerging Asia Pacific ETF
GMF
$440M
$667K ﹤0.01%
7,604
-3,023
-28% -$272K
FBK icon
2337
FB Financial Corp
FBK
$3.1B
$663K ﹤0.01%
18,927
-1,265
-6% -$46.4K
KN icon
2338
Knowles
KN
$3.23B
$663K ﹤0.01%
49,846
-3,955
-7% -$57.9K
CAF
2339
Morgan Stanley China A Share Fund
CAF
$327M
$662K ﹤0.01%
36,239
-25,219
-41% -$487K
CMC icon
2340
Commercial Metals
CMC
$7.98B
$661K ﹤0.01%
41,285
-1,115
-3% -$20.8K
EBS icon
2341
Emergent Biosolutions
EBS
$230M
$661K ﹤0.01%
11,155
+416
+4% +$26.8K
CVEO icon
2342
Civeo
CVEO
$344M
$658K ﹤0.01%
38,363
+2,405
+7% +$71K
NUVA
2343
DELISTED
NuVasive, Inc.
NUVA
$657K ﹤0.01%
13,252
-28,162
-68% -$1.69M
CZR
2344
DELISTED
Caesars Entertainment Corporation
CZR
$657K ﹤0.01%
96,742
-332,498
-77% -$2.8M
PCEF icon
2345
Invesco CEF Income Composite ETF
PCEF
$823M
$656K ﹤0.01%
32,440
-19,457
-37% -$415K
UUP icon
2346
Invesco DB US Dollar Index Bullish Fund
UUP
$414M
$656K ﹤0.01%
+25,775
New +$662K
SOS
2347
SOS Limited
SOS
$16.7M
$655K ﹤0.01%
86
-4
-4% -$62.4K
UEIC icon
2348
Universal Electronics
UEIC
$66.6M
$655K ﹤0.01%
25,926
-1,661
-6% -$53.8K
NTWK icon
2349
NetSol Technologies
NTWK
$49.3M
$654K ﹤0.01%
106,369
SPH icon
2350
Suburban Propane Partners
SPH
$1.17B
$654K ﹤0.01%
33,964
-3,999
-11% -$90K

Similar funds

Raymond James & Associates's Q4 2018 Portfolio in Review

As of Q4 2018, Raymond James & Associates held 3,843 positions worth $57.4B, down 11% from $64.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q4 2018 filing shows 205 new, 1,398 increased, 1,819 reduced and 309 closed positions. Its largest new stake was Linde: 549,404 shares worth $87.1M. The largest sale was Oracle, an estimated $124M.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, down from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q4 2018 buy was Linde: 549,404 shares worth $87.1M.
  • Raymond James & Associates added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $368M increase.
  • Raymond James & Associates's biggest Q4 2018 reduction was Oracle, cutting an estimated $124M.
  • Raymond James & Associates fully exited Praxair Inc in Q4 2018, selling an estimated $110M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $57.4B portfolio in Q4 2018.
  • Raymond James & Associates opened 205 new positions and closed 309 in Q4 2018.
  • Raymond James & Associates's portfolio value fell 11% quarter-over-quarter to $57.4B.

Based on Raymond James & Associates's 13F filing for Q4 2018, filed 11 Feb 2019.